Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

9825	Companies
197283	Keywords
128415	Articles
104954	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 10/23/2025 at 07:57, 3 months 18 days ago

Heidelberg Pharma’s Lead ADC Candidate HDP-101 Granted Fast Track Designation by US FDA for the Treatment of Multiple Myeloma
Heidelberg Pharma's lead ADC candidate HDP-101 granted Fast Track Designation by US FDA for the treatment of multiple myeloma. Accelerated review for innovative cancer therapy

Heidelberg Pharma Multiple Myeloma Fast Track Designation ADC Candidate US FDA
BRIEF

published on 10/09/2025 at 07:08, 4 months 1 day ago

Bilan de l'activité pharmaceutique Heidelberg pour les neuf premiers mois de 2025

Résultats Financiers Essais Cliniques Heidelberg Pharma HDP-101 Ajustement De La Stratégie
BRIEF

published on 10/09/2025 at 07:08, 4 months 1 day ago

Heidelberg Pharma's Nine-Month Update for 2025

Financial Results Clinical Trials Heidelberg Pharma HDP-101 Strategy Adjustment
PRESS RELEASE

published on 10/09/2025 at 07:03, 4 months 1 day ago

Heidelberg Pharma Reports on the First Nine Months of Financial Year 2025
Heidelberg Pharma AG reports operational progress and financial figures for the first nine months of fiscal year 2025, focusing on lead ADC candidate HDP-101 and cost-saving measures

Financial Report Clinical Trial Cost-saving Measures Heidelberg Pharma AG ADC Candidate
BRIEF

published on 10/06/2025 at 16:03, 4 months 3 days ago

Heidelberg Pharma AG Revises Financial Guidance for 2025

Financial Guidance Heidelberg Pharma ADCs Operating Expenses Cash Requirements
BRIEF

published on 10/06/2025 at 16:03, 4 months 3 days ago

Heidelberg Pharma AG révise ses prévisions financières pour 2025

Heidelberg Pharma ADC Orientation Financière Dépenses D'exploitation Besoins De Trésorerie
PRESS RELEASE

published on 10/06/2025 at 15:58, 4 months 3 days ago

EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance
Heidelberg Pharma AG adjusts its financial guidance for 2025, focusing on cost-saving measures. Sales, operating expenses, and cash requirements revised

Sales Financial Guidance Cost-saving Measures Heidelberg Pharma AG Operating Expenses
BRIEF

published on 09/25/2025 at 13:22, 4 months 14 days ago

Heidelberg Pharma Advances HDP-101 in Clinical Trial for Multiple Myeloma

HDP-101 Multiple Myeloma Safety Profile Phase I/IIa Trial Clinical Activity
BRIEF

published on 09/25/2025 at 13:22, 4 months 14 days ago

Heidelberg Pharma fait progresser le HDP-101 dans un essai clinique pour le myélome multiple

HDP-101 Myélome Multiple Profil De Sécurité Essai De Phase I/IIa Activité Clinique
PRESS RELEASE

published on 09/25/2025 at 13:17, 4 months 14 days ago

Heidelberg Pharma Advances to Cohort 9 in Phase I/IIa Trial of Lead ATAC Candidate HDP-101 in Multiple Myeloma
Heidelberg Pharma advances to Cohort 9 in Phase I/IIa trial of lead ATAC candidate HDP-101 in multiple myeloma, demonstrating favorable safety profile and early signs of clinical activity

Heidelberg Pharma Multiple Myeloma ATAC Candidate Phase I/IIa Trial Clinical Activity

Accesswire

Published on 02/10/2026 at 08:00, 35 minutes ago

Caledonia Mining Corporation Plc - Issue of Securities Pursuant to Long Term Incentive Plan Awards
Published on 02/10/2026 at 01:05, 7 hours 30 minutes ago

Notification of Relevant Change to Significant Shareholder
Published on 02/09/2026 at 23:35, 9 hours ago

Mako Mining Announces Intention to Restructure the Mt. Hamilton Acquisition Consideration and Postponement of Special Meeting of Shareholders to New Meeting Date of March 3, 2026
Published on 02/09/2026 at 23:15, 9 hours 20 minutes ago

IBC Advanced Alloys to Present at the Precious Metals & Critical Minerals Virtual Investor Conference on February 10, 2026
Published on 02/09/2026 at 23:08, 9 hours 27 minutes ago

NV Gold Announces Closing of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 02/10/2026 at 08:00, 35 minutes ago

Transaction in Own Shares
Published on 02/10/2026 at 07:00, 1 hour 34 minutes ago

EQS-Adhoc: ams OSRAM post Q4 above mid-point of guidance, delivers EUR 144 m FCF in FY25 and launches EUR 200 m ‘Simplify’ transformation and savings program
Published on 02/10/2026 at 07:00, 1 hour 35 minutes ago

Waga Energy: Croissance de +23 % des revenus de production de biométhane en 2025
Published on 02/10/2026 at 07:00, 1 hour 35 minutes ago

TUI delivers best Q1 performance with Und. EBIT of €77m, growing strongly by +€26m. We reaffirm our FY26 guidance of +7-10% Und. EBIT growth (at CC), driven by expectations for Summer 2026
Published on 02/10/2026 at 07:00, 1 hour 35 minutes ago

Waga Energy posts a +23% yoy RNG production revenue growth

Les Echos

Published on 02/09/2026 at 18:00, 14 hours 35 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 14 hours 50 minutes ago

Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 14 hours 50 minutes ago

DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 14 hours 50 minutes ago

Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 14 hours 50 minutes ago

Déclaration des droits de vote à fin janvier 2026

View all LES ECHOS COMFI WIRE